发明名称 VACCINE AGAINST NEWCASTLE DISEASE
摘要 FIELD: medicine; biotechnologies. ^ SUBSTANCE: vaccine contains virus material from "La-Sota" strain, saccharose, enzymatic peptone, casein, aerosil AM-1-300 and resin KB-4P-2. At that virus material from "La-Sota" strain used in vaccine is suspension from whole hen's eggs with developed 12-13-day embryos infected with culture of "La-Sota" strain at 9-10 day of their incubation. Vaccine also additionally contains alpha-tocopherol with the following ratio of components, wt %: suspension from whole hen's eggs with developed 12-13-day embryos infected with culture of "La-Sota" strain at 9-10 day of their incubation - 10.73-12.47, saccharose - 4.16-4.60, enzymatic peptone - 2.50-3.06, casein - 0.83-1.53, alpha-tocopherol - 0.04-0.08, aerosil AM-1-300 - 1.00-2.00, resin KB-4P-2 - the rest. ^ EFFECT: high immunogenicity, harmlessness for bird and ecological safety for servicing personnel. ^ 4 tbl, 5 ex
申请公布号 RU2347584(C1) 申请公布日期 2009.02.27
申请号 RU20070142924 申请日期 2007.11.22
申请人 FEDERAL'NOE GOSUDARSTVENNOE UCHREZHDENIE "VSEROSSIJSKIJ GOSUDARSTVENNYJ TSENTR KACHESTVA I STANDARTIZATSII LEKARSTVENNYKH SREDSTV DLJA ZHIVOTNYKH I KORMOV" (FGU "VGNKI") 发明人 SHUL'GINA ZHANNA LEONIDOVNA;GOREVA IRINA PROKOF'EVNA;RUDENKO TAT'JANA VLADISLAVOVNA;SMOLENSKIJ VLADIMIR IVANOVICH;RAD'KOV VJACHESLAV NIKOLAEVICH;GRIGORENKO ARKADIJ IL'ICH
分类号 A61K39/17;A61P31/12 主分类号 A61K39/17
代理机构 代理人
主权项
地址